Acadia alert: bragar eagel & squire, p.c. is investigating acadia pharmaceuticals, inc. on behalf of long-term stockholders and encourages investors to contact the firm

New york--(business wire)-- #a--bragar eagel & squire, p.c., a nationally recognized shareholder rights law firm, is investigating potential claims against acadia pharmaceuticals, inc. (nasdaq: acad) on behalf of long-term stockholders following a class action complaint that was filed against acadia on april 19, 2021 with a class period from june 15, 2020 to april 4, 2021. our investigation concerns whether the board of directors of acadia have breached their fiduciary duties to the company. aca.
ACAD Ratings Summary
ACAD Quant Ranking